Exploring Perceptions of HPV Risks and Motivations to Vaccination in MSM at a Community-Based HIV Clinic.

Johnathon S Lueck, Lovesimrjit S Sandhu, Jessica Richman, Crystal Walker, Jon Philip Trujillo, Daniel Callahan, Aidan Collier Smith, Srinivas J Ivatury

Abstract read

PubMed Publisher

In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Johnathon S LueckDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA. johnlueck@utexas.edu.ORCID http://orcid.org/0000-0001-9135-2068

Lovesimrjit S SandhuDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.ORCID http://orcid.org/0009-0009-4272-7965

Jessica RichmanDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.

Crystal WalkerDavid Powell Health Center, Austin, TX, USA.

Jon Philip TrujilloDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.

Daniel CallahanDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.

Aidan Collier SmithDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.

Srinivas J IvaturyDell Medical School, The University of Texas at Austin, 1501 Red River Street, Austin, TX, 78712, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anal cancer incidence has risen significantly over the past four decades, with HIV-positive men who have sex with men (HIV + MSM) facing a disproportionately higher disease burden. Although human papillomavirus (HPV) vaccination can prevent most HPV-related cancers, uptake remains low within this population. To explore perceptions of HPV infection and vaccination, this study employed a cross-sectional survey based on the Health Belief Model (HBM). Recruitment took place at a federally qualified health center in Austin, Texas, serving primarily low-income people living with HIV. Biological males over 18 years old, who have sex with men and are HIV-positive, were eligible. A 36-item survey assessed demographics, sexual behavior, and awareness of HPV and the HPV vaccine within the context of the HBM. Among 49 participants, only 22.45% had received at least one dose of the HPV vaccine. Of those who were unvaccinated, only 23.68% planned to receive the HPV vaccine within the next six months. Overall HPV knowledge was low, with fewer than half recognizing HPV's role in anal cancer. Among the vaccine acceptance group (participants who were vaccinated or intended to be vaccinated), there was a higher perceived severity of HPV-related disease, greater perceived benefits of vaccination, fewer perceived barriers, and a stronger response to physician recommendations. Cost was the only barrier notably linked to non-acceptance. These findings highlight an urgent need to address gaps in awareness of HPV's link to anal cancer and underscore how key HBM constructs-particularly high perceived severity and benefits, and low barriers-predict vaccine acceptance. Interventions should focus on informing HIV + MSM about their susceptibility and emphasizing healthcare provider recommendations. Although the small sample size and single-site recruitment limit generalizability, this study offers critical insights into HPV-related perceptions among HIV + MSM, underscoring the importance of targeted strategies to boost vaccination and reduce HPV-related cancer in this underserved group.

Indexed as

Anus NeoplasmsHealth Knowledge, Attitudes, PracticeHIV InfectionsHomosexuality, MaleMotivationPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareVaccinationAdultCross-Sectional StudiesHealth Belief ModelHumansMaleMiddle AgedSexual BehaviorPapillomavirus VaccinesAnal cancerHealth Belief ModelHIV + MSMHPV vaccinationHuman papillomavirusMen who have sex with men

Identifiers

PMID40451987

DOI10.1093/cid/cir1036

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.